GlassScriptPhysician profile
Ted Butterfield
NPI 1396003638
$1,659.16
in general payments reported to CMS, 2019-2025
21 companies · $33.46 in 2025
The $33.46 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $31.76 · 2022: $164 · 2023: $249 · 2024: $48.53 · 2025: $33.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $775.00 | 2019 | |
| Melinta Therapeutics, LLC | $214.11 | 2019-2022 | |
| Horizon Therapeutics Plc | $134.86 | 2019-2023 | Krystexxa |
| Bioventus LLC | $115.33 | 2023 | Sonicone Clinic |
| Smith+Nephew, INC. | $64.22 | 2019-2025 | Grafix Pl, Stravix |
| Kci USA, INC. | $59.25 | 2023 | V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Organogenesis INC. | $37.64 | 2019-2020 | |
| Acera Surgical, INC. | $28.16 | 2019 | |
| Averitas Pharma INC. | $25.92 | 2023 | Qutenza |
| Goode Surgical INC | $25.62 | 2024 | |
| Alfasigma USA, INC. | $23.78 | 2022 | |
| Nevro Corp. | $20.81 | 2022 | |
| Osiris Therapeutics INC. | $20.16 | 2019 | |
| Abbvie INC. | $17.65 | 2023 | Dalvance |
| Cumberland Pharmaceuticals, INC. | $16.95 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $16.74 | 2025 | Promogran Prisma, Prevena, Activ.A.C. |
| Orthofix Medical, INC. | $14.36 | 2019 | |
| Depuy Synthes Sales INC. | $13.51 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.40 | 2019 | |
| Boston Scientific Corporation | $11.65 | 2022 | |
| Stimwave Technologies Incorporated | $11.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Butterfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.